Authors: Graf, LL Young, DA Kressin, DC Marlar, RA Jacob, GB Hinderling, PH

Citation: Ll. Graf et al., Inhibition of thrombin by iopromide in vitro, THER DRUG M, 23(2), 2001, pp. 93-99

Authors: Saul, JP Schaffer, MS Karpawich, PP Erickson, CC Epstein, MR Melikian, AP Shi, J Karara, AH Cai, B Hinderling, PH

Citation: Jp. Saul et al., Single-dose pharmacokinetics of sotalol in a pediatric population with supraventricular and/or ventricular tachyarrhythmia, J CLIN PHAR, 41(1), 2001, pp. 35-43

Authors: Hinderling, PH

Citation: Ph. Hinderling, Biased estimates of nonrenal clearance, J PHARM SCI, 90(7), 2001, pp. 960-966

Authors: Saul, JP Ross, B Schaffer, MS Beerman, L Melikian, AP Shi, J Williams, J Barbey, JT Jin, J Hinderling, PH

Citation: Jp. Saul et al., Pharmacokinetics and pharmacodynamics of sotalol in a pediatric populationwith supraventricular and ventricular tachyarrhythmia, CLIN PHARM, 69(3), 2001, pp. 145-157

Authors: Hinderling, PH

Citation: Ph. Hinderling, Red blood cells: A neglected compartment in pharmacokinetics and pharmacodynamics. (vol 49, pg 279, 1997), PHARM REV, 52(3), 2000, pp. 473-473

Authors: Barbey, JT Sale, ME Woosley, RL Shi, J Melikian, AP Hinderling, PH

Citation: Jt. Barbey et al., Pharmacokinetic, pharmacodynamic, and safety evaluation of an accelerated dose titration regimen of sotalol in healthy middle-aged subjects, CLIN PHARM, 66(1), 1999, pp. 91-99